BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
18.49
+1.50 (8.83%)
Apr 17, 2026, 4:00 PM EDT - Market closed
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $820.58 million as of April 17, 2026. Its market cap has increased by 555.85% in one year.
Market Cap
820.58M
Enterprise Value
541.01M
1-Year Change
555.85%
Ranking
Category
Stock Price
$18.49
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has increased from $615.01M to $820.58M, an increase of 33.43%. That is a compound annual growth rate of 20.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 820.58M | 72.99% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evotec SE | 1.18B |
| Alvotech | 1.13B |
| Collegium Pharmaceutical | 1.12B |
| Amphastar Pharmaceuticals | 1.04B |
| Cronos Group | 1.03B |
| Pacira BioSciences | 1.00B |
| Tilray Brands | 797.32M |
| Ironwood Pharmaceuticals | 722.35M |